Key Record Dates
ClinicalTrials.gov Identifier: | NCT04268706 |
---|---|
Brief Title: | Phase 2 Study Evaluating Autologous CD30.CAR-T Cells in Patients With Relapsed/Refractory Hodgkin Lymphoma (CHARIOT) |
First Submitted : | February 11, 2020 |
First Submitted that Met QC Criteria : | February 12, 2020 |
First Posted : | February 13, 2020 |
Last Update Submitted that Met QC Criteria : | April 4, 2023 |
Last Update Posted : | April 5, 2023 |